Sigachi Industries Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/boxopttlckpn9vk0t02aer2c.pdf

Key Takeaways


Demand & Volume

Amit Raj Sinha: "What we have seen in the last couple of months is that there has been a slight slowdown in our demand understanding from the developed markets. That's primarily the EU and the US region. We believe that it is kind of temporary and hopefully we will have the 4th quarter being better than the 3rd quarter."

Revenue Mechanics: Realization, Freight & Mix


Capacity Expansion & Capex


Diversification: Premix, OTC, API & Acquisitions

Amit Raj Sinha: "I believe that when the company is small and flexible, there is a lot possible. When it becomes big and rigid, it gets difficult. The downside of getting into all of this is absolutely nil. There is no downside, there is no negative."

Costs, Margins & Employee Expense


Governance & Capital Allocation

Amit Raj Sinha: "Saket sir, I would put it the other way. I would put it that if the promoter is so confident in borrowing money and growing the company, everybody else should be happy about it."

Guidance & Commitments

CommitmentSpecificsTimeline
Q4 revenue run-rate₹80 cr/quarter endorsed as a fair estimateQ4 FY23 through Q2 FY24
Dahej & Jhagadia capex commercialization₹58–60 cr capex turning into sales on balance sheetQ3 FY24 (Q2 FY24 commissioning)
CCS plant environmental clearanceApproval expected; civil work commences immediately upon receiptWithin 6 months
CCS plant commissioning15 months (optimistic) to 18 months (pessimistic) from approval15–18 months post-EC approval
Premix & OTC revenue contributionAt least ₹10–12 cr eachFY24
Overall revenue growth target20% driven by new capacities in core productFY24
Segmental reporting (MCC vs O&M)To be provided if requiredFrom next quarter onwards
Long-term growth aspirationMinimum 25% YoY while defending EBITDA margins5-year horizon

Key Metrics

MetricQ3 FY23
Operating income₹69 cr, up ~5% YoY
EBITDA₹14 cr, up ~10% YoY
EBITDA margin20.35%
Net profit~₹10 cr, up ~3% YoY
PAT margin14.24%
9M FY23 operating income~₹230 cr, up 29% YoY
9M FY23 EBITDA₹46.5 cr, up 21% YoY
9M FY23 EBITDA margin20.25%
9M FY23 net profit~₹36 cr, up 27.5% YoY
9M FY23 PAT margin15.77%
9M FY23 revenue growth split2% volume growth and 17% realization growth YoY
9M FY23 capacity utilization91% overall; Dahej 85%, Jhagadia 97%, Hyderabad 94%
9M FY23 volume sold9,859 metric tons, up 2% YoY from 9,567 metric tons
9M FY23 average realization₹217.14 per unit
O&M income₹6.85 cr in Q3; ₹17.67 cr in 9M FY23 vs ~₹13.4 cr in prior full year
Employee cost₹10 cr, up from ₹8.29 cr QoQ, driven by field staff deployment for OTC/generics and ONGC O&M contract
Total capacity>13,800 MTPA currently, expanding to 21,000 MTPA via ongoing CAPEX
CAPEX for Dahej and Jhagadia expansion~₹58–60 cr, to be capitalized upon commercial production expected by Q2 FY24
Fund-raise planned~₹300 cr for expansion into intermediates and APIs
Preferential warrant issuance1.10 cr warrants; 50 lakh from promoter category, 25% upfront payment, balance 75% over 18 months
Premix and OTC expected revenue in FY23~₹2 cr each from trial lots and dispatches
Premix and OTC expected revenue in FY24at least ₹10–12 cr each
Full-year FY23 volume guidance~13,000 to nearly 14,000 metric tons
Working capital cycle~90 days
9M FY23 other income₹5 cr, including ~₹3 cr foreign exchange gain